Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-20 | Dec-05-20 | Dec-31-19 | Dec-05-19 | Dec-31-18 |
| 10-K | 10-K | 8-K | S-1/A | 8-K | S-1/A |
Revenues: |
United States | 2,759.0 | 2,353.0 | | | | |
Rest of World | 373.0 | 375.0 | | | | |
Total revenues | 3,132.0 | 2,728.0 | 2,728.0 | | 2,552.0 | |
Revenue growth | | | 6.9% | | | |
Cost of goods sold | 2,136.0 | 0.0 | 1,894.0 | | 1,669.0 | |
Gross profit | 996.0 | 2,728.0 | 834.0 | | 883.0 | |
Gross margin | 31.8% | 100.0% | 30.6% | | 34.6% | |
Selling, general and administrative | 671.0 | | 461.0 | | 415.0 | |
Other operating expenses | 283.0 | 2,728.0 | 226.0 | | 203.0 | |
EBITDA [+] | 381.0 | 291.0 | 638.0 | | 703.0 | |
EBITDA growth | | | -9.2% | | | |
EBITDA margin | 12.2% | 10.7% | 23.4% | | 27.5% | |
Depreciation | 79.0 | 91.0 | 291.0 | | 253.0 | |
EBITA | 302.0 | 200.0 | 347.0 | | 450.0 | |
EBITA margin | 9.6% | 7.3% | 12.7% | | 17.6% | |
Amortization of intangibles | 316.0 | 200.0 | 200.0 | | 185.0 | |
EBIT [+] | -14.0 | 0.0 | 147.0 | | 265.0 | |
EBIT growth | | | -44.5% | | | |
EBIT margin | -0.4% | 0.0% | 5.4% | | 10.4% | |
Interest expense | 122.0 | | | | | |
Interest expense | 122.0 | 204.0 | | | | |
Other income (expense), net [+] | 95.0 | 110.0 | -241.0 | | -227.0 | |
Other | 16.0 | | | | | |
Pre-tax income | -41.0 | -94.0 | -94.0 | | 38.0 | |
Income taxes | 31.0 | 9.0 | 9.0 | | 16.0 | |
Tax rate | | | | | 42.1% | |
Minority interest | -10.0 | | | | | |
Net income | -62.0 | 0.0 | -103.0 | | 22.0 | |
Net margin | -2.0% | 0.0% | -3.8% | | 0.9% | |
|
Basic EPS [+] | ($0.14) | | ($103.00) | | $22.00 | |
Growth | | | -568.2% | | | |
Diluted EPS [+] | ($0.14) | | ($103.00) | | $22.00 | |
Growth | | | -568.2% | | | |
|
|
Shares outstanding (basic) | 458.6 | | 1.0 | | 1.0 | |
Growth | | | 0.0% | | | |
Shares outstanding (diluted) | 458.6 | | 1.0 | | 1.0 | |
Growth | | | 0.0% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|